ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Testosterone and Depression Symptoms in Aging Men
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 276309" data-attributes="member: 13851"><p><em><strong>*On treatment, median serum testosterone rose from 7.8 nmol/L (227 ng/dl) at baseline to 14.7 nmol/L (424 ng/dl) on treatment, <u>substantially below the mid-normal range (19.0 nmol/L, 550 ng/dl) reflecting the low serum SHBG of obesity and probable suboptimal compliance with daily gel application given the study’s high dropout rate</u>. Whether higher on-treatment testosterone concentrations would have better effects remains speculative.</strong></em></p><p><em><strong></strong></em></p><p><em><strong>*<em> <strong>While TRAVERSE provides sound evidence for short-term cardiovascular safety of testosterone treatment of aging men with pre-existing cardiovascular disease, <u>longer-term safety beyond 2 years remains to be established.</u> <u>Nor did TRAVERSE provide reassurance on the unprecedented T-Trials finding that 12 months of testosterone treatment increased non-calcified coronary plaque </u>(7).</strong></em></strong></em></p></blockquote><p></p>
[QUOTE="madman, post: 276309, member: 13851"] [I][B]*On treatment, median serum testosterone rose from 7.8 nmol/L (227 ng/dl) at baseline to 14.7 nmol/L (424 ng/dl) on treatment, [U]substantially below the mid-normal range (19.0 nmol/L, 550 ng/dl) reflecting the low serum SHBG of obesity and probable suboptimal compliance with daily gel application given the study’s high dropout rate[/U]. Whether higher on-treatment testosterone concentrations would have better effects remains speculative. *[I] [B]While TRAVERSE provides sound evidence for short-term cardiovascular safety of testosterone treatment of aging men with pre-existing cardiovascular disease, [U]longer-term safety beyond 2 years remains to be established.[/U] [U]Nor did TRAVERSE provide reassurance on the unprecedented T-Trials finding that 12 months of testosterone treatment increased non-calcified coronary plaque [/U](7).[/B][/I][/B][/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Testosterone and Depression Symptoms in Aging Men
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top